chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fourteen hrs after receiving the Covid booster vaccine, my bones, muscles and skin started hurting quite severely.  At the same time I was freezing and my temp was 101.8. This came on very quickly and lasted 22 hours and for the next 24 hrs I was extremely fatigued. I have never felt so sick in my life.
Generalized erythematous rash trunk, arms, legs, back with pruritus.  Patient seen by medical doctor 9/18/06.
Pt received both doses of the Pfizer COVID-19 vaccine, on 3/31/21 and 4/20/21.  He then presented to the ER on 6/29/2021 for an unrelated reason (DKA) and was tested per protocol for COVID-19 prior to admission.  This test on 6/29/2021 was positive.  Pt reports having a mild cold about a week ago, with a mild cough on presentation to the ER.  EMR also indicates that he had COVID 12/2020 (fatigue, loss of taste, cough).
A large, near baseball size, lump formed over my left shoulder blade about 6 inches from the injection site.  I noticed it when I went to change shirts ~4 hours after getting the shot.
multiple sclerosis, 1 1/2yr- 1 1/4yr, daily inj copotene;fatigue, weakness, excessive pain back, ankles, feet;syncope;some hair loss (excessive but not to the point of baldness);
had been vaccinated, still got the shingles/ suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster Shingles vaccine for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, his or her friend had been vaccinated and still got the shingles really bad. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were not provided.
I started having red itchy rashes 10 days later which might be the incubation period. 2 days later I started having sharp pain on my right chest until now even after taking pain killer Advil and Gabapentin as well as shingles medicine Valacyclovir
Pt received Engerix B onset of both feet aching, pitting edema hands,feet & lower legs o 1st dose lasted 48 hrs, recovered /w out treatment
Patients upper arm from elbow to shoulder became pink, warm to touch, and painful. He also had fever of 101 F. Symptoms started approximately 8 hours after injection.
Dizziness, stomach discomfort, intermittent blindness for 3 days.
Received vaccine on 4/14/23 and noticed redness in upper arm on 4/21/23. Redness increasing throughout the day.  Injection site itchy. Swollen lymph nodes under left arm since 4/19/23.
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. On or about 03-DEC-2012, at a pharmacy, the patient was vaccinated with ZOSTAVAX, as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 03-SEP-2012 (note: conflicting information: the date of vaccination is after the onset date of herpes zoster), the patient was treated by a physician  for the onset of a severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as severe herpes zoster, or shingles. The patient has been prescribed VALTREX for management of her painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful juries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
6 hours after injection had severe flushing of skin. Moderate to severe itching minor swelling of face and throat. Started to subside in 30 minutes or so. Went home took a Benadryl and slept for two hours.   Had severe tiredness and some minor nausea.
Localized reaction to flu shot treated as cellulitis. Left arm. Emergency visit copy attached. 10/4/18 Pt doing well per mother. She did not come for f/u. 9/28/2018, Swelling of the left arm, got flu shot. 12-year-old male with history of egg and mild allergy being evaluated in the emergency department for swelling of the left upper arm. He got his flu shot yesterday. In the night he noticed some swelling around the shot site. It was also hurting making him a little bit more increased which prompted the ED visit. He is able to move his arm well. Denies any drainage. Denies any fever. Denies any wheezing or difficulty breathing.
Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium
This case was reported by a consumer via call center representative and described the occurrence of rash in a child female patient who received KINRIX. The patient's past medical history included anaphylaxis and allergy. Concurrent medical conditions included milk allergy, egg allergy and peanut allergy. In June 2017, the patient received the 2nd dose of KINRIX .5 ml. In June 2017, 1 day after receiving KINRIX, the patient experienced rash, itchy legs, crying and scratch. On an unknown date, the outcome of the rash, itchy legs, crying and scratch were recovered/resolved. The reporter considered the rash to be possibly related to KINRIX. It was unknown if the reporter considered the itchy legs, crying and scratch to be related to KINRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient no longer had a milk allergy, however, 24 hours after receiving the KINRIX vaccine, the patient's mother said that the patient's legs itched so bad and the patient was crying and scratching her thighs. The patient's mother noticed that on both thighs the patient had a rash that was itchy so she washed her legs and she gave her some BENADRYL and the rash resolved. The reporter described the rash like tiny hives. When the patient received the KINRIX vaccine, they were not aware that it was not her final DTaP and Polio vaccine so she might need another vaccine.
had the flu; unable to receive her second vaccine because she had the flu and shortly thereafter the Pandemic started.; This case was reported by a consumer via call center representative and described the occurrence of influenza in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 27th September 2019, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced influenza and social problem. On an unknown date, the outcome of the influenza and social problem were unknown.   It was unknown if the reporter considered the influenza to be related to Shingrix.  Additional details were reported as follows: Patient stated that she was unable to receive her 2nd dose of Shingrix vaccine because she had the flu and shortly thereafter the Pandemic started. The reporter did not consented to follow-up.
This case was reported in a published article, regarding a Vaccine court special master in a decision released April 27 rejected the government's contention that a fetus allegedly injured by a vaccine administered to the mother had not "received" that vaccine under the terms of the act. The special master ruled in 2001 that the patient who suffered from Aicardi's syndrome, could not be said to have "received" the MMR vaccine in utero based on the most restrictive plausible meaning of the word as required at the time by the act's waiver of sovereign immunity. The special master said that he held the case on abeyance in the event that Congress addressed the issue, but instead, he said, the petitioners moved for reconsideration based on an intervening Court decision in physician Security Service. Under physician, the special master said, he may rule for the more persuasive definition, rather than the most limiting. Given that the act was a "remedial" statute, under physician, he said the more persuasive interpretation that the developing fetus receives a vaccine given in the mother event though it had neither ingested not been injected with it as described in the act. It was reported that it was concluded in 2001, that the statutory language was ambiguous in its application to this situation, and that both competing interpretations were at least "plausible" by the special master. Therefore, he concluded, that he was not free to choose the interpretation that he found to be more persuasive. He was bound under the 1990s cases rather, to choose the interpretation that would produce the most narrow and restricted waiver of sovereign immunity. In light on the physician opinion, however, the special master stated that he was free to weigh relative merits of the two competing interpretations. Further, physician specified that he was free to consider general principles of statutory construction other than the sovereign immunity canon of narrow construction, he could take into account the statutory consideration of liberal construction of remedial statutes. The special master directed the patient's parents to determine whether they could obtain an expert report that the vaccine likely progressed through the patient's mother body into the fetus she was carrying and, if so, whether it caused the patient's seizure disorder, brain malformation and significant developmental delay. The representing parent patient's information was reported. Additional information is not expected.
Before vaccine my blood pressure averaged 125/82 and I was not on meds. After vaccine it was 155/85 ave. My dr started me on bp meds. The meds did not seem to help. Even on meds bp shot up to 176/108. Dr doubled my bp meds. Still High now but not as high.
pt recv vax & 6hr later reported was very sick-sx of chills, fever, h/a & runny nose;on f/u myalgias, rhinorrhea, sl productive cough & low grade fever 101;
mild headache; tiredness; This is a spontaneous report from a contactable other healthcare professional reported for himself (patient). A 52-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: 5130) into right arm on 17Dec2020 10:00 AM at single dose for covid-19 immunization in Public health. Medical history was not reported. Other medications in two weeks included irbesartan (AVAPRO), amlodipine besilate (NORVASC) and HCTZ. No other vaccine in four weeks (Also reported "other vaccine same date product was PFIZER, other vaccine same date lot number was 1600, other vaccine same date dose number was 2, other vaccine same date vaccine location was Right arm", pending clarification). Patient experienced mild headache and tiredness on 17Dec2020 07:00 PM. No covid prior vaccination. Covid test post vaccination via Blood test with unknown results. No treatment received. outcome of the events was unknown.
arm all red; nausea; cold; freezing every bone; body ached; still not feeling well; This case was reported by a consumer via interactive digital media and described the occurrence of erythema of extremities in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced erythema of extremities, nausea, cold, feeling cold, general body pain and feeling unwell. On an unknown date, the outcome of the erythema of extremities, nausea, cold, feeling cold and general body pain were unknown and the outcome of the feeling unwell was not recovered/not resolved.   It was unknown if the reporter considered the erythema of extremities, nausea, cold, feeling cold, general body pain and feeling unwell to be related to Shingles vaccine.  Additional details were provided as follows: The patient self reported this case. The age at vaccination was not reported. The patient just had his/her last shot and it was worst shot. The patient had arm all red, nausea and got a cold and freezing every bone in his/her body ached. The patient was still not feeling well. The follow-up could not be possible as no contact details were available.
pt recvd vax;2 days later,exp fever,rash,ear infect,conjunctivitis,arthritic joints,irritability & a 5% weight loss; outcome unresolved;
This spontaneous report as received from a nurse practitioner refers to a patient (gender and age not reporter) which was vaccinated with PNEUMOVAX23 (dose and route not provided) which was exposed to 11.5 C for 103.5 hours. No adverse effect reported. Lot number H022281 is an invalid lot number for PNEUMOVAX23. This is one of several reports received from same source. Additional information is not expected.
Patient received expired pfizer, expiration date in fridge was 3/26/22, no adverse effects per patient
Shortly after 15 min. I got a rapid  pulse , when I got home I checked it and it was 131 resting, started feeling faint and nausea,. My husband had a stop watch. and I tried it and and it said atrial fribulation repeatedly for over an hour and  half. So I went to the ER, but before I left I took my  metropole and when I got tot he hospital they did a EKG, but by the time I got to the ER and did the EKG I was a typical.  I was discharged that same night, I saw my cardiologist 5 days later  on 11/2/2022 and he put me on losartan  50 mg.  I have to got back next Tuesday 11/15/22  for an Echocardiogram and wear a Holter for 2 weeks.
After taking the COVID-19 booster shot from Pfizer/BioNTech, I feel nauseas every time I wake up in the morning.  Although the feeling goes away after a couple of minutes, the feeling comes back the next morning.
Initial symptoms started with itching on right arm, then all over.  She used Benadryl with no relief.  Then Used Calamine Lotion with no relief.  Then noticed about a week later started with a rash on multiple sites in various parts on entire body.  Then Pain started all over body aches.  Especially in groin region and it moves. Headaches started approx. 10 days later and using Aleve with no improvement, then Motrin with some improvement. Rash continues.
Fever, Full Body Pain, Headache, Chills, Night Sweats, Nausea, Dizziness, Large Red Mark (near around shot area), Pain in right underarm, sever Stomach pain. I took over the counter cold/flu medicine and Tylenol. I had all of the symptoms from 8:00am Sunday (  6-26-21) and Monday (6-27-21) until Tuesday (6-29-21) at 4:00pm. I am still having an elevated temperature of 99.9/100 every night and night sweats. I usually take Tylenol PM around 9:00pm at night but doesn't seem to be helping.
Patient states that 3 days after receiving her COVID-19 Bivalent Booster she developed a rash on her right arm (opposite of the shot) that has been spreading for 5 days. She also had symptoms of shortness of breath, fever and general aches and pains for the first 2 days after the vaccine was administered but those side effects have resolved. She went to urgent care on 10/21/2022 where the doctor on call prescribed her Triamcinolone 0.5% ointment to be applied twice daily for 7 days and also Prednisone 20mg tablets: 2 tablets once daily for 5 days.
Swelling back of neck lasted 2 hours, arm pain for  24 hours: tiredness ongoing past 2 days; flushed face, but no fever.  Headache 24 hours.
reports adverse sxs began 530PM & inc in severity to 9PM-fever, chills & joint pain;next day exp flu like sxs, sweating & numbness in lt arm & both hands, dark amber urine, tiredness, lighthead, flushed, blurred vision, blister on elbow
PROQUAD was administered to a 14 year old patient.; This spontaneous report was received from an educator referring to a 14-year-old patient. Information regarding the patient's pertinent medical history, historical drugs, concurrent conditions, concomitant therapies, and previous drug reactions or allergies was not reported.   On 31-AUG-2020, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live, recombinant human albumin (rHA) (PROQUAD) lot # S035111, expiration date 03-MAY-2021, at a dose of 2.5 milliliter for prophylaxis. The reporter stated they are aware of the prescribing information that measles, mumps, rubella and varicella (oka-merck) virus vaccine live, recombinant human albumin (rHA) (PROQUAD) should be administered between 12 months and 12 years. The reporter stated the patient had their initial dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live, recombinant human albumin (rHA) (PROQUAD) on 10-OCT-2019 and that the dose on 31-AUG-2020 was the second in the series. The reporter was requesting information on how to proceed, if the patient's dose was valid.
SHINGRIX was reconstituted with sterile water instead of diluent from manufacturer. No adverse effects reported, but patient may not have adequate coverage against shingles.
Vaccine Administration Error- Patient wanted a Moderna Booster (previously received Janssen as her primary series), however received a Pfizer Booster instead. Patient was understanding and did not seem to have any adverse effect.
PAIN IN AXILLA AND TORSO ON SIDE WHER VACCINATION RECIEVED.  NO ERYTHEMA OR LYMPHADENOPATHY.
Presented to ED with sudden onset tachycardia/atrial flutter 145-150bpm, admitted to ICU on cardizem and heparin drip. Currently still in ICU 11/17/2021
This spontaneous report as received from a pharmacist refers to her 18 year old daughter. The patient was vaccinated (route not reported) with dose 1 GARDASIL (lotnumber and expiry date not reported) on unspecified dates. No other co-suspects were reported. Concomitant medications included: hormonal contraceptives (unspecified) . The pharmacist reported that her daughter later developed tonsillitis and the Dengue fever on 21-DEC-2012. The pharmacist also reported that her daughter was supposed to receive the third dose of GARDASIL on 07-JAN-2013, but she was still sick so she didn't receive it. The event was treated was TYLENOL. Unspecified lab work was performed. The outcome of tonsillitis, Dengue fever and was still sick was reported as recovering/resolving. The outcome of supposed to receive the third dose of GARASIL on 07-jan-2013 is unknown. The relatedness for tonsillitis, was still sick, supposed to receive the third dose of GARDASIL on 07-jan-2013 and Dengue fever is unknown for GARDASIL. Additional information has been requested.
p/vax pt exp dimples & yellowing around the site p/vax;pt exp yellow/whitehead pimples around inj site w/some itching;
bilateral sites- swelling redness  rash induration heat  LA only- some tingling from site  onward distally , intermittent x 4 days
Had a light headache starting a few hours after vaccination (4/22), but wasn't sure it was due to vaccine. Woke up at 3:00am (4/23) with intense chills/shivers. Got up for the day at 7:00am and took ibuprofen (didn't take temp, but most certainly had one). Was achy and exhausted, light headache persisted from night before. From 8:30 - 11:00am had crazy back to back cycles of being on fire and then chills (seemingly flipping every 5-10 minutes). Headache became more intense and persisted through until 4 pm. Took ibuprofen at 11:30, 4:30pm, and 8:00pm when fever spiked again (took temp).  Drank plenty of water throughout the day and many naps. I sweated through my clothes several times after having my fever break. Aches, weakness, and exhaustion lasted throughout the day and night. Woke up the following day (4/24) with no symptoms except still a little fatigued despite getting almost 11 hours of sleep.
Information has been received from a nurse in the physician's office and a 66 year old female nurse with diabetes, hypertension, asthma, allergic reaction to quinolones antibiotics, sulfonamide allergy, shellfish allergy, reaction to monosodium glutamate, allergy to pine nuts, soy products and mushrooms and a history of non-Hodgkin's lymphoma diagnosed in July 1996 who on 08-FEB-2007 was vaccinated IM in the left arm with a dose of Zostavax. Concomitant therapy included SYNTHROID, ALTACE, ATACAND, sitagliptin phosphate, PLAVIX, vitamins (unspecified), ubidecarenone (co-enzyme Q-10), aspirin, omega-3 marine triglyceride (fish oil) and TENEX. On approximately 09-FEB-2007, within 24 hours of vaccination, the patient developed a rash. The left arm injection site became red, inflamed and swollen. This reaction took a "few days to resolve." The patient was seen in the office at the end of February with complaints of sore throat, swollen glands, chills and coughing which was diagnosed as an upper respiratory infection (the patient reported that these symptoms started within 72 hours after vaccination and she felt that these symptoms in addition to feeling "wiped out" were symptoms of an asthma reaction). The patient was started on therapy with erythromycin. It was reported that the patient had to stop singing in the choir for the past six weeks due to the coughing. It was reported that the patient continued to have a dry cough. "In the past two weeks", starting on approximately 17-APR-2007 the patient developed night sweats. At the time of the report the patient was recovering, she had not been seen in the office since her last visit in the end of February 2007. There was no product quality complaint involved. It was reported that the patient's chemotherapy regimen for her non-Hodgkin's lymphoma was as follows: course 1 in the beginning of 2002, course 2 at the end of 2002, course 3 in the middle of 2003, course 4 at the end of 2003, course 5 in the middle of 2004 and course 6 in the beginning of 2005. The patient had a routine follow-up CT scan in January 2007 which was normal, she was due for a repeat CT scan in July 2007. No further information was provided. Additional information has been requested. This is in follow-up to report(s) previously submitted on 06/14/2007. Additional information noted that the patient developed "asthma/bronchitis" with "coughing/wheezing." The patient followed up in the office on 07-MAY-2007 and it was noted that the erythromycin helped though the patient was reported to be not recovered. Lab test was "normal." No further information was provided. Additional information received noted that the patient recovered on 15-FEB-2007. Additional information is not expected.
Case number PHEH2014US019416 is an initial spontaneous report from the nurse received on 24 SEP 2014. This report refers to an adult (at her 50's) female patient. On 23 SEP 2014, she was inadvertently vaccinated with 0.5 ml FLUVIRIN 2014/2015 (batch number: 1411001) via subcutaneous route as it was administered with a TB needle. No adverse event reported following these medication errors (inappropriate route of vaccine administration and wrong technique in drug usage process).
DTP/HIB/OPV on 15SEP92 t98 ax; 16SEp92 onset of hives; seen in office dx erythema multiforme; 17SEp t101.4; 18SEP t98 ax, erythema multiforme improved;
Lost taste and smell. Very fatigued, also chest pain. Went to PCP and was told symptoms were common. Pt also, saw Cardiologist, Urologist, and Pulmonologist.
Information has been received from a health professional concerning an adult male patient who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot 651329/1047P).  Subsequently, the patient complained of redness, warmth and soreness at the injection site.  Unspecified medical attention was sought.  At the time of this report, the patient's outcome was unknown.  No product quality complaint was involved.  Additional information is not expected.